Ann: ResApp Joins Startup Creasphere Digital Health Program, page-49

My point is one is definitely undervalue (currently I don't think PCK is undervalue) and I agree on the IP, RAP has a machine learning algorithm which has proven to be able to be robust and quickly adjust to detect OSA so this will be worth something to big tech company.....but the market always look at revenue (unless a big tech company buyout RAP for just their algorithm, and if you are investing based on that, you need to decide how much that IP is worth???)